Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation

Johnson, G. K.; Saeian, Kia; Geenen, Joseph E.

doi:10.1007/s11894-006-0011-y

Cited by 26 publications

(8 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…, brushings or biopsies to rule out dysplasia). 143–146 Stenting may be additionally performed, but the latter alone may be sufficient and may incur fewer complications. 147–149 …”

Section: Complicationsmentioning

confidence: 99%

Primary sclerosing cholangitis: A review and update

Tabibian

Bowlus

2017

Liver Research

View full text Add to dashboard Cite

Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease of uncertain etiology characterized biochemically by cholestasis and histologically and cholangiographically by fibro-obliterative inflammation of the bile ducts. In a clinically significant proportion of patients, PSC progresses to cirrhosis, end-stage liver disease, and/or hepatobiliary cancer, though the disease course can be highly variable. Despite clinical trials of numerous pharmacotherapies over several decades, safe and effective medical therapy remains to be established. Liver transplantation is an option for select patients with severe complications of PSC, and its outcomes are generally favorable. Periodic surveillance testing for pre- as well as post-transplant patients is a cornerstone of preventive care and health maintenance. Here we provide an overview of PSC including its epidemiology, etiopathogenesis, clinical features, associated disorders, surveillance, and emerging potential therapies.

show abstract

“…, brushings or biopsies to rule out dysplasia). 143–146 Stenting may be additionally performed, but the latter alone may be sufficient and may incur fewer complications. 147–149 …”

Section: Complicationsmentioning

confidence: 99%

Primary sclerosing cholangitis: A review and update

Tabibian

Bowlus

2017

Liver Research

View full text Add to dashboard Cite

show abstract

“…Continuing inflammation eventually results in the development of benign biliary strictures, usually of the EHBD, and they have been reported in up to 7% of patients within 10 years [30][31][32] . Patients usually present increased jaundice, pruritus or relapsing bacterial cholangitis.…”

Section: Cholelithiasis Choledocholithiasis and Biliary Stricturesmentioning

confidence: 99%

Primary sclerosing cholangitis - What is the difference between east and west?

Shorbagi¹,

Bayraktar²

2008

WJG

View full text Add to dashboard Cite

Primary sclerosing cholangitis (PSC) is a chronic, progressive, cholestatic liver disease characterized by inflammation and fibrotic obliteration of the hepatic biliary tree. It is commonly associated with inflammatory bowel disease (IBD). A number of complications can occur which require special consideration, the most important of which is the development of cholangiocellular carcinoma (CCC). Unfortunately, no medical therapy is currently available for the underlying liver disease. Liver transplantation is an effective, lifeextending option for patients with advanced PSC. Geographical variations between East and West include a second peak for age with a lower association with IBD in a Japanese population and female predominance in a lone study from Turkey. The clinical and biochemical Mayo criteria may not be universally applicable, as different patients show variations regarding the initial presentation and natural course of the disease. Directing research towards explaining these geographical differences and understanding the pathogenesis of PSC is required in order to develop better therapies for this devastating disease.

show abstract

“…Even so, therapeutic intervention should be reserved for sympto matic patients since there is no evidence of benefit for treatment of asymptomatic subjects (171,176,177) . Prophylactic antibiotics are recom mended for prevention of postprocedure bacterial cholangitis in patients with PSC who undergo ERCP (171,176,177) . Treatment of DS should be performed either by balloon or passage dilators (171,176,177) .…”

Section: Dominant Strictures In Pscmentioning

confidence: 99%

“…Prophylactic antibiotics are recom mended for prevention of postprocedure bacterial cholangitis in patients with PSC who undergo ERCP (171,176,177) . Treatment of DS should be performed either by balloon or passage dilators (171,176,177) . Stent placement after dilation is not routinely recommended as it can increase the risk of bacterial cholangitis.…”

Section: Dominant Strictures In Pscmentioning

confidence: 99%

Recommendations for Invasive Procedures in Patients With Diseases of the Liver and Biliary Tract: Report of a Joint Meeting of the Brazilian Society of Hepatology (Sbh), Brazilian Society of Digestive Endoscopy (Sobed) and Brazilian Society of Interventional Radiology and Endovascular Surgery (Sobrice)

Schiavon

Ejima

Menezes

et al. 2019

Arq. Gastroenterol.

View full text Add to dashboard Cite

Liver and biliary tract diseases are common causes of morbidity and mortality worldwide. Invasive procedures are usually performed in those patients with hepatobiliary diseases for both diagnostic and therapeutic purposes. Defining proper indications and restraints of commonly used techniques is crucial for proper patient selection, maximizing positive results and limiting complications. In 2018, the Brazilian Society of Hepatology (SBH) in cooperation with the Brazilian Society of Interventional Radiology and Endovascular surgery (SOBRICE) and the Brazilian Society of Digestive Endoscopy (SOBED) sponsored a joint single-topic meeting on invasive procedures in patients with hepatobiliary diseases. This paper summarizes the proceedings of the aforementioned meeting. It is intended to guide clinicians, gastroenterologists, hepatologists, radiologists, and endoscopists for the proper use of invasive procedures for management of patients with hepatobiliary diseases.

show abstract

Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation

Cited by 26 publications

References 48 publications

Primary sclerosing cholangitis: A review and update

Primary sclerosing cholangitis: A review and update

Primary sclerosing cholangitis - What is the difference between east and west?

Contact Info

Product

Resources

About